Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LEN✓SelectedUSD · LENGSK vs LEN performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs LEN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
LEN return
-30.7%
Excess return
+83.5%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioLENExcessAlpha
1D-0.1%+1.0%-1.1%-0.3%
7D-5.3%-3.4%-1.9%-4.7%
30D-3.7%+3.9%-7.6%-4.4%
3M-7.3%-4.9%-2.4%-6.7%
6M-4.2%-6.4%+2.1%-3.6%
YTD+0.9%-19.7%+20.6%+3.5%
1Y+7.3%-29.0%+36.3%+12.3%
3Y+52.7%-31.5%+84.3%+59.1%
All+52.7%-30.7%+83.5%+59.1%

Cumulative growth

Daily Returns

Daily percentage return beside LEN.

Daily Out/Under-Performance

Portfolio return minus LEN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded LEN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling